Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distr…
$0.40-0.69%
报价 2026-11-06
市值
$939,338
EV
$14.7M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -100.0%
$0.40$950.25
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| JAGXJaguar Health, Inc. | $939,338 | -0.7% | -80.2% | 82.3% | – | – | – | |
| KZIAKazia Therapeutics Limited | $11.6M | +2.6% | – | 100% | – | – | – | |
| INMInMed Pharmaceuticals Inc. | $8.5M | +17.8% | – | 14.9% | – | – | – | |
| CNSPCNS Pharmaceuticals, Inc. | $5.7M | -2.2% | +75.9% | 0% | – | – | – | |
| GRIGRI Bio, Inc. | $4.1M | +21.3% | -100.0% | 0% | – | – | – | |
| CANFCan-Fite BioPharma Ltd. | $2.1M | +1.3% | – | 100% | – | – | – | |
| SXTP60 Degrees Pharmaceuticals, Inc. | $2.1M | -35.1% | +35.7% | 19.4% | – | – | – | |
| CLDICalidi Biotherapeutics, Inc. | $1.8M | +3.1% | – | 0% | – | – | – | |
| SILOSilo Pharma, Inc. | $1.5M | +3.1% | 0.0% | -474.3% | – | – | – | |
| 同行中位数 | – | – | +17.9% | 7.4% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。